To investigate whether potential epigenetic modifications of PIEZO1 could be associated with early brain dysfunction, we analysed PIEZO1 DNAm in infants with a diagnosis of ND aged between 3 and 36 months. The gene discussed is PIEZO1; the disease is Norrie disease.